PainReform Ltd. (PRFX)
NASDAQ: PRFX
· Real-Time Price · USD
2.22
-0.20 (-8.26%)
At close: May 01, 2025, 3:59 PM
2.30
3.60%
After-hours: May 01, 2025, 04:00 PM EDT
-8.26% (1D)
| Bid | 2.21 |
| Market Cap | 4.18M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -17.67M |
| EPS (ttm) | -32.16 |
| PE Ratio (ttm) | -0.07 |
| Forward PE | -0.07 |
| Analyst | n/a |
| Ask | 2.33 |
| Volume | 34,449 |
| Avg. Volume (20D) | 2,008,249 |
| Open | 2.37 |
| Previous Close | 2.42 |
| Day's Range | 2.22 - 2.38 |
| 52-Week Range | 0.43 - 16.63 |
| Beta | 0.72 |
About PRFX
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the tre...
Sector Healthcare
IPO Date Sep 1, 2020
Employees 2
Stock Exchange NASDAQ
Ticker Symbol PRFX
Website https://www.painreform.com
2 months ago
+31.56%
PainReform shares are trading higher after the com...
Unlock content with
Pro Subscription
4 months ago
-28.57%
PainReform shares are trading lower. The company announced an update regarding its Phase 3 clinical trial evaluating PRF-110 in post-surgical pain management of patients undergoing bunionectomy.
